BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 7669439)

  • 1. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
    Qi H; Li M; Wronski TJ
    J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD; Wronski TJ
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.
    Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ
    Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats.
    Mosekilde L; Søgaard CH; McOsker JE; Wronski TJ
    Bone; 1994; 15(4):401-8. PubMed ID: 7917578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct stereological estimation of three-dimensional connectivity in rat vertebrae: effect of estrogen, etidronate and risedronate following ovariectomy.
    Boyce RW; Wronski TJ; Ebert DC; Stevens ML; Paddock CL; Youngs TA; Gundersen HJ
    Bone; 1995 Feb; 16(2):209-13. PubMed ID: 7756049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ; Yen CF; Qi H; Dann LM
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.
    Mosekilde L; Danielsen CC; Gasser J
    Endocrinology; 1994 May; 134(5):2126-34. PubMed ID: 8156913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model.
    Mosekilde L; Thomsen JS; McOsker JE
    Bone; 1997 May; 20(5):429-37. PubMed ID: 9145240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates.
    Søgaard CH; Wronski TJ; McOsker JE; Mosekilde L
    Endocrinology; 1994 Feb; 134(2):650-7. PubMed ID: 8299562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.
    Hunziker J; Wronski TJ; Miller SC
    J Dent Res; 2000 Jun; 79(6):1431-8. PubMed ID: 10890724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.
    Jia HB; Ma JX; Ma XL; Yu JT; Feng R; Xu LY; Wang J; Xing D; Zhu SW; Wang Y
    Osteoporos Int; 2014 Dec; 25(12):2743-54. PubMed ID: 25074352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats.
    Ejersted C; Oxlund H; Eriksen EF; Andreassen TT
    Bone; 1998 Jul; 23(1):43-52. PubMed ID: 9662129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.
    Søgaard CH; Mosekilde L; Thomsen JS; Richards A; McOsker JE
    Bone; 1997 May; 20(5):439-49. PubMed ID: 9145241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.
    Shen V; Birchman R; Xu R; Otter M; Wu D; Lindsay R; Dempster DW
    J Clin Invest; 1995 Nov; 96(5):2331-8. PubMed ID: 7593620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.